Inari Medical, Inc. (NARI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 07, 2025

$79.45

P/E Ratio

N/A

Market Cap

$4.65B

Jan 17, 2024Feb 21, 2024Mar 27, 2024May 3, 2024Jun 6, 2024Jul 9, 2024Aug 8, 2024Sep 12, 2024Oct 17, 2024Nov 22, 2024Jan 7, 2025$0.00$10.00
  • F34
Description

Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.

Metrics

Overview

  • HQIrvine, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerNARI
  • Price$79.45+22.23%

Trading Information

  • Market cap$4.65B
  • Float85.91%
  • Average Daily Volume (1m)2,898,850
  • Average Daily Volume (3m)1,514,567
  • EPS-$1.35

Company

  • Revenue$574.50M
  • Rev growth (1yr)21.39%
  • Net income-$18.37M
  • Gross margin84.71%
  • EBITDA margin-0.83%
  • EBITDA-$1.28M
  • EV$2.33B
  • EV/Revenue4.05
  • P/EN/A
  • P/S8.07
  • P/B10.68
Documents